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ABSTRACT

ANGIOGENESIS IN RESPONSE TO VARYING FIBER SIZE IN AN ELECTROSPUN
SCAFFOLD IN VIVO

Damien Ellis Brown, Master of Science

A thesis in partial fulfillment of the requirements for the degree of Master of Science in
Anatomy and Neurobiology at Virginia Commonwealth University

Virginia Commonwealth University, 2012

Director: Raymond J. Colello, D.Phil
Associate Professor, Department of Anatomy and Neurobiology

Injury to the spinal cord results in partial or complete loss of sensory perception
and motor function. After spinal cord injury (SCI), damaged tissue dies and a cavity will
form. This cavity prevents the regeneration of tissue and any functional recovery. One
way to address the cavity is the insertion of an electrospun scaffold that our lab has
created. This provides a substrate for regenerating tissue to grow on, and it is thought
that reestablishing the blood supply within the scaffold will allow cells necessary for
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regeneration to thrive. This could ultimately lead to meaningful recovery for patients who
have suffered SCI. Full spinal cord transections were performed on rats, and the
scaffolds were inserted into the lesion site. Two different types of scaffold were tested to
see if altering the fiber size in the scaffolds produced more blood vessels, and ultimately
better regeneration of tissue.
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Chapter 1
Spinal Cord Injury, Related Pathology, and the Role of Angiogenesis in Recovery

Synopsis:
Defining Spinal Cord Injury
Spinal cord injury (SCI) occurs when there is an insult to the structures
composing the spinal cord, causing disruption to the signaling pathways between the
brain and the rest of the body. Depending on the level and severity of the injury, there is
typically a loss of sensory information and motor function below the site of the lesion.
This is a direct result of the severing of axons, the neuronal structures which carry
information to and from the brain, and the death of cells which surround axons and
supports their proper function. Specifically, disruption to the vasculature results in loss
of trophic and metabolic support needed for proper cellular function.
Immediately following the initial insult to the spinal cord tissue, there are a host of
secondary events which cause further damage resulting in an inability of the cells to
regenerate. As is typical in most injuries, there is an innate immune and inflammatory
response in the injured area. With regard to the central nervous system (CNS), injury to
the spinal cord results in a far greater immune response than similar injuries to the

1

brain. It has been shown that SCI results in 2-4 times the amount of macrophage,
lymphocyte, and neutrophil infiltration than similar injuries to the brain, illustrating the
very delicate and sensitive nature of this structure (Schnell, Fearn, Klassen, Schwab, &
Perry, 1999).This immune response releases many substances which drive the neurons
and supporting cells (glia) into programmed cell death (Emery et al., 1998). The death
of these cells leaves behind cellular debris which elicits further immune response, as
well as preventing axonal regeneration. In addition to this, glial cells known as
astrocytes surround the injury site activate, become enlarged and divide rapidly creating
a scar which encases the damaged tissue (Figure 1.1). This scar acts as a barrier that
not only physically inhibits axon growth, but the cells composing the scar release
compounds that further block regeneration (Sofroniew & Vinters, 2010). As the
damaged cells within the scar die off and are cleared away, the result is an acellular
environment which fills with fluid presenting a physical gap which further retards
regeneration (Fawcett, 2006).
The complex nature of these events complicates the treatment of SCI
tremendously. Many approaches are being explored which attempt to address and
overcome these obstacles. Utilizing different combinatorial strategies helps to mitigate
the initial inflammatory response and facilitate functional recovery. This thesis will
explore the use of an electrospun scaffold as a therapeutic strategy to overcome some
of the obstacles of SCI. Using a complete spinal cord transection model in rats
replicates many of the issues that are present in different types of SCI. We will examine
the histology associated with the implant, focusing on the angiogenic response and the
ability of the scaffold to direct the establishment of a new vascular supply. We will first
2

examine the anatomy of the spinal cord and importance of the blood supply. We will
then introduce types of SCI and related pathology. Then we will look closer at the
factors which prevent regeneration in the injured spinal cord, and the ways in which our
therapeutic strategy addresses them. We will later compare the normal blood supply in
spinal cord tissue to the re-establishment of new vasculature through the implanted
electrospun scaffold.
Introduction:
Anatomy of the Spinal Cord
The human spinal cord is one of the most complex cellular networks in the body,
composed of over one billion neurons. The human spinal cord is an ovoid grouping of
neurons, and is approximately 45cm in length. It begins just below the medulla
oblongata near the foramen magnum of the skull, and extends all the way down through
the spinal column terminating in the upper lumbar region. There are two distinct regions
that compose the majority of the spinal cord; the white and gray matter. White matter
refers to the outermost area of the spinal cord which is composed of efferent and
afferent axonal tracts. These tracts are responsible for relaying the motor signals
leaving the brain, and the sensory information returning from the periphery. Damage to
the white matter is commonly seen in SCI, and is the primary reason for the loss of
sensation and function. The gray matter is located in the core of the spinal cord and
houses the neuronal cell bodies of the axons. These cell bodies play a central role in
motor control, central pattern generation, and reflex loops.
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The spinal cord maintains a uniform thickness except in two regions, the cervical
and lumbar enlargements. These two regions have a greater amount white matter due
to the fact that these are the levels at which innervation of both the upper and lower
limbs take place. Due to its sensitive nature, there are several protective elements
which surround the spinal cord to protect it from injury. The three meninges of the
brain, the dura mater, aracnoid mater, and the pia mater also extend down into the
spinal canal encapsulating the spinal cord. Cerebrospinal fluid surrounds the spinal
cord acting as a shock absorber, preventing the spinal cord from hitting the walls of the
surrounding spinal column.
Spinal Cord Blood Supply
The vascular network which feeds the spinal cord is an integral piece of the
neural network. It supplies oxygen and other necessary nutrients to the cells within the
spinal cord, as well as carrying away metabolic waste. The blood supply to the spinal
cord originates from the vertebral arteries, thoracic and lumbar segmental arteries, and
deep and ascending cervical arteries. The anterior spinal artery branches off of the
vertebral arteries, running the entire length of the spinal cord (Martirosyan et al., 2011).
The anterior spinal artery supplies the anterior two thirds of the spinal cord along with
central core of gray matter. The posterior spinal arteries branch into the pial
circumferential arteries which supply the remaining one third, the posterior spinal cord
and peripheral white matter. The anterior and posterior spinal arteries anastomose
around the conus medularis in what is known as the arterial basket (Lamin and
Bhattacharya 2003). (Figure 1.2)
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The Blood Spinal Cord Barrier
The cardiovascular system in humans is a complex network which distributes
blood throughout the body to the various tissues and organ systems. The vascular
supply is responsible for many homeostatic processes such as gas exchange, nutrient
delivery and pH balance. When one examines the vascular supply associated with the
Central Nervous System (CNS) as opposed to rest of the body, there is one notable
difference. Due to the sensitive nature of the brain, spinal cord, and associated nervous
tissue, the body has evolved a specialized vascular network with strict regulation of
exchange between the blood and the interstitial fluid of the CNS. This particular feature
of the CNS vascular supply is known as the Blood Brain/ Blood Spinal Cord Barrier
(BBB/BSCB). For the purposes of this paper, we will be referring to the BSCB. The
BSCB is the network which regulates what passes from the blood into the spinal cord,
as well as prohibiting immune cells access to the brain and spinal cord. Often with
contusional SCI, there is disruption to the BSCS which allows infiltration of immune cells
and exposure to neurotoxic compounds. Along with the reestablishment of the
vasculature, repair of the BSCB is also a crucial step in creating an environment that is
conducive to regeneration and proper neurologic function.
The arteries of the spinal cord turn into arterioles as they enter the parenchyma
of the spinal cord, and end when they reach the level of the capillaries. The BSCB is
present at the capillary level and is maintained by specialized endothelial cells (ECs)
that share tight junctions with neighboring ECs. Other cells which interact with these
EC’s also contribute to the BSCB and include astrocytes, pericytes, and neuronal
processes. Together they form what is known as the neurovascular unit (Figure 1.3),
5

and all play a role in the regulation of blood flow and membrane transport of substances
into and out of the spinal cord microenvironment (Benarroch, 2012).
Classification of Spinal Cord Injury
The term spinal cord injury is a broad classification of the very complex, widely
varied types of injuries which exist. There are a number of different ways that an
individual can sustain damage to the spinal cord; insults to the undamaged cord (Figure
1.4A) include squeezing, crushing or tearing of the cord, or more invasive means such
as lacerations from objects penetrating the spinal column. For these reasons, more
specific classes were created in order to identify the gross appearance, means in which
the injury was sustained, and the associated histology. There are four distinct
categories into which an injury can be classified; solid cord injuries, contusion/cavitation
injuries, laceration injuries, and massive compression injuries.
Solid Cord Injury
This class of SCI accounts for approximately 10% of all cases. From a gross
anatomical perspective the spinal cord looks normal, but when examined at a
histological level a loss of typical cellular architecture is seen (Figure 1.4B). With most
SCI the cause of the injury is readily apparent; with solid cord injuries the exact cause is
not fully understood. It is believed that this type of SCI has an underlying inflammatory
component which results in the loss of the delicate cellular networks within the spinal
cord. The primary insult which causes secondary inflammation is thought to be from
some form of mechanical stress, such as sudden stretching or squeezing of the spinal
cord (Norenberg, Smith, & Marcillo, 2004).
6

Contusion/Cavitation Injury
This form of SCI is the most common, representing approximately 50% of all
cases encountered. The cause of contusion/ cavitation injuries occur when the vertebra
of the spinal column or the vertebral discs are dislocated and press against the spinal
cord causing bruising. Being that there is no physical penetration in this type of injury,
the protective meningeal layers are left intact. Despite the lack of tissue disruption
during the initial insult, bleeding within the central gray matter leads to an inflammatory
response and ultimately necrosis of the tissue. Once dead tissue has been removed by
the inflammatory cells, the result is a fluid filled cyst (Figure 1.4C). Along with this,
reactive astrocytes begin to proliferate and surround the damaged area, resulting in the
formation of what is known as the gliotic scar (Norenberg et al., 2004).
Laceration Injury
The laceration injury represents nearly 20% of SCI cases seen. This type of
injury can be caused when broken pieces of a damaged vertebra pierce the meninges
and damage the spinal cord (Figure 1.4D). Other causes of this type of injury are from
foreign objects penetrating the spinal column; often this is the result of violent acts such
as gun shots and stabbings. The disruption of the meninges allows for infiltration of
cells not normally present in the spinal cord, particularly influx of fibroblasts which begin
to deposit collagen. This deposition leads to the formation the mesenchymal scar, which
hinders the ability of axons to regenerate (Norenberg et al., 2004).
Massive Compression Injury
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This type of SCI accounts for a little less than 20% of SCI cases reported. As the
name suggests, massive compression injuries occur when the spinal cord is crushed by
some physical force, usually a fall or blunt force trauma. As is seen with laceration
injuries (Figure 1.4E)., the meninges are often damaged leading to similar fibroblastic
invasion and scar formation (Norenberg et al., 2004).
Clinical Classification
The functional outcome of a SCI is what determines the clinical classification.
The classification categories are known as complete, incomplete or discomplete. A
complete injury is one in which total loss of motor function and sensory information is
experienced below the site of the lesion. In an incomplete injury, some form of sensory
or motor function is retained indicating that some of the axonal tracts have been left
intact. The final classification is what is known as discomplete, and is the most
misunderstood of the three. This is when an injury appears to be complete, yet there is
still some conscious control over areas below the site of the lesion.
SCI Pathology
The most common form of SCI experienced is the contusion/cavitation injury. It is
for this reason that our has uses a complete spinal cord transection which reflects the
type of problems encountered with this type of injury. There are many physical
limitations associated with SCI that must be overcome, and we will examine these
limitations in upcoming sections.
Immediately after a traumatic injury, the spinal cord experiences inflammation
and edema. This inflammatory cascade leads to cell death in the area of inflammation.
8

The severing of neuronal cells from there source of neurotrophic support also
contributes to the massive cell death associated with SCI. A process known as reactive
astrogliosis results in the formation of an impenetrable network of cells which ultimately
result in scar formation. Also known as the gliotic scar, this tight grouping of astrocytes
presents a physical barrier which regenerating axons cannot pass (Sofroniew, 2005).
Cells within the scar undergo a process known as liquefactive necrosis, ultimately
leading to the formation of the fluid filled cyst. The cyst itself is the ultimate barrier to
regeneration being that it is a physical gap in the tissue, providing no structure on which
axons and blood supply can regenerate.
Reactive Astrogliosis and the Gliotic Scar
Astrocytes are glial cells found throughout the nervous system which play many
complex supportive roles. They participate in such processes as synaptic function,
blood flow regulationand ionic balance. Astrocytes also play a key role in the proper
functioning of the BBB/BSCB. When the CNS is subjected to an insult, astrocytes
surrounding the injury site change morphology and begin a process which is referred to
as reactive astrogliosis. During this process, the cells become enlarged and begin to
divide rapidly. The reactive cells begin to amass around the injury site forming a dense
cellular structure called the gliotic scar (Sofroniew, 2009). The reactive astrocytes play a
key role in restructuring the spinal cord architecture by creating new extracellular matrix
(ECM). One of the most important functions of the new ECM is to provide a framework
for endothelial cells to begin forming new vasculature (White & Jakeman, 2008). It is
this vascular supply which provides the metabolic support necessary for survival of
neural tissue, and is necessary for any meaningful recovery. The gliotic scar is a
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protective mechanism which helps to minimize damage and further loss of tissue, but it
also has many negative affects which prevent the regeneration of axons.
The processes of the reactive astrocytes form tight junctions with one another
producing what is known as the glial limitans. This resulting barrier is instrumental in
separating normal from damaged tissue, as well as preventing the spread further
necrosis. This protective barrier, however, also acts as a wall through which
regenerating axons and blood vessels cannot cross. One particular compound that is
released by cells of the gliotic scar is known as chondroitin sulfate proteoglycan
(CSPG). Proteoglycans are structural elements consisting of a protein core with
polysaccharides attached along its length. CSPGs are glycosaminoglycans which have
been sulfated, and have been shown to inhibit the regeneration of axons (White &
Jakeman, 2008).
The Fluid-filled Cyst
One of the major barriers to overcome after a contusional SCI is the formation of
the fluid-filled cyst. The cyst formation takes place over the course of a few weeks to
months after the initial injury. The size and number of cysts present can vary depending
on the extent of the damage sustained. The cysts form in the damaged area contained
within the gliotic scar, and are the result of the removal of the cellular debris. This fluid
filled acellular cavity has no inherent structure on which regenerating cells can grow,
and prevents revascularization and axonal regeneration from taking place (Cholas, Hsu,
& Spector, 2012)(Hagg & Oudega, 2006).
Vascular Disruption following SCI
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Damage to the blood supply in the spinal cord is thought to be the key factor in
the progression of degenerative effects seen in SCI. Hemorrhaging of damaged vessels
disrupts nutrient and oxygen delivery to cells, leading to cell death (Rooney et al.,
2009). Along with this initial insult, secondary injury can occur to surrounding tissue that
would otherwise remain intact. The compromised BSCB allows inflammatory molecules
and immune cells access to neurons causing further cell death (Whetstone, Hsu,
Eisenberg, Werb, & Noble-Haeusslein, 2003). In addition to this, the response of the
cardiovascular system to SCI includes decreased cardiac output and bradycardia, along
with hypotension resulting in further ischemia (Mautes, Weinzierl, Donovan, & Noble,
2000). One of the major impediments to axonal regeneration and functional recovery is
this damage to the vascular network. Without the recovery of this crucial element, cell
survival and proliferation cannot occur.
Treating SCI: Inducing angiogenesis as a therapeutic strategy
Within the realm of SCI research, the focus of most therapeutic strategies is the
regeneration of axons. While this is a necessary step to meaningful recovery, the
importance of reestablishing a properly functioning blood supply is very often neglected.
Understanding the angiogenic process and applying this information in a therapeutic
strategy may be one of the greatest and most overlooked tools available in treating SCI
and may other disease states.
The Mighty Endothelial Cell
Throughout the vascular system, at the core of any vessel there is the endothelial
cell. ECs line the inside of all vessels throughout mammalian circulatory system, and it
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was once believed that ECs were a cell type of little importance with little variation.
Upon further examination ECs have been shown to vary greatly in size, orientation,
appearance, and function. ECs participate in many essential physiological functions
including vasoconstriction and dilation, fibrinolysis, antigen presentation, catabolism of
lipoproteins, blood coagulation, transportation of blood cells, adaptive and innate
immunity, and angiogenesis (Aird, 2012).
The phenotype of ECs can vary widely between organs, vessel types, and even
neighboring ECs. They can be very tightly arranged in a fashion referred to as
continuous, or loosely arranged in what is known as fenestrated as well as
discontinuous. These types of orientation are directly related to the needs of the
particular system and its associated tissues. In large arterial sections ECs are arranged
along the longitudinal axis of blood flow in order to cope with the shear stress
associated with the large volumes and pressures, as opposed to those found in veins
(Flaherty et al., 1972). In the CNS, ECs have stronger tight junctions and highly
regulated channels to accommodate its strict metabolic requirements. In systems such
as the kidneys, ECs are assembled in a fenestrated fashion allowing for the filtration of
the blood.
Understanding the role ECs play in regenerative as well as well as disease states
is something that is essential in treating SCI as well as many other maladies present in
a clinical setting. When treating many diseases, the focus tends to be more
macroscopic in scale; more attention is paid to the vessels or the blood due to their
accessibility. Due to the tight association of ECs with each other and the lumen of the
vessel, ECs are difficult to isolate and study. Due to these complications, the great
12

importance and possible wealth of therapeutic techniques involving the endothelium has
been largely ignored.
Angiogenesis vs. Vasculogenesis
There is often much confusion and debate about the difference between
angiogenesis and vasculogenesis. It is important to have an understanding of the two
in order to have an appreciation for the roles that each one plays in a biological system.
While there is some interplay between them early on in development, for the most part
angiogenesis and vasculogenesis are two distinct processes.
Vasculogenesis is described as the series of events that take place during the
establishment of the initial capillary plexus. During vasculogenesis, mesodermally
derived cells differentiate into angioblasts or hemangioblasts, and then further
differentiate into endothelial cells and hematopoietic cells respectively. There is then an
organization of ECs into the primary capillary plexus (Pepper, Mandriota, Vassalli, Orci,
& Montesano, 1996).
Angiogenesis is a process that takes place after the initial establishment of a
vascular network. This process involves the formation of newly formed vessels via
sprouting or seeding from pre-established blood vessels. Angiogenesis takes place
during many different developmental processes, such as the formation of blood vessels
in the placenta, or in other physiologic states such as the formation of the corpus lutem
during ovulation in females. Angiogenesis can also be associated with many
pathological states, such as in tumor formation or rheumatoid arthritis (Pepper et al.,
1996). One of the most important functions of angiogenesis is its involvement in
13

maintenance and preservation of an organism. In processes such as inflammation,
wound healing or response to an ischemic event, angiogenesis is of the utmost
importance (Cassell, Hofer, Morrison, & Knight, 2002).
Angiogenesis in response to injury
There are a host of factors which are a part of the angiogenic response post
injury. Two major angiogenic processes can occur following an injury; one involves
vessel sprouting from existing vessels, while the other arises through the seeding of
circulating EC’s, and is referred to as non-sprouting (Risau, 1997). During the EC
seeding process, one major factor involved is the Vascular Endothelial Growth Factor
(VEGF). Following spinal cord injury, vascular disruption causes the cells in the spinal
cord to become hypoxic releasing hypoxia-inducible factor (HIF). The mechanism that is
believed to trigger the release of HIF is the production of reactive oxygen species (ROS)
from the mitochondria within the hypoxic cells. These compounds are required for HIF
transcription factors to increase gene expression for VEGF release (Chandel et al.,
2000). The VEGF then binds to VEGF receptors on endothelial cells, causing a tyrosine
kinase cascade. This cascade triggers the breakdown of the basal lamina of existing
blood vessels, allowing the release of ECs and the seeding of new vessels within the
surrounding tissue (Risau, 1997).
During the sprouting angiogenic process, the extracellular matrix is degraded and
proliferation and migration of endothelial cells occur. The sprouting occurs at the ends
of the existing vessels, and these sprouts produce long extensions of the endothelial
cells toward the areas requiring revascularization (Mackenzie & Ruhrberg, 2012). It is
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believed that cells producing VEGF produce the chemotactic gradient which directs the
sprouting. However, in either case revascularization is hindered by the physical gap
produced by the cystic cavity, and requires some type of substrate on which both the
seeding and sprouting processes can occur.
Engineering angiogenesis
The reestablishment of a functional blood supply is a necessary step on the road
to regeneration. Angiogenesis is a mechanism that the body uses in response to
injuries, and is crucial in wound healing. However, care must be taken in the amount of
angiogenesis that occurs as well as the quality of the vessels that are created.
With regard to the spinal cord, the newly formed vasculature should parallel that
of the original blood supply. The ideal result would be similar vessel distribution, as well
as comparable vessel permeability. The permeability of the newly formed vessels is
important to consider due to the fact that the vessels in the spinal cord have very low
permeability due to the BSCB. Some disease states such as multiple sclerosis are
associated with increased vessel permeability (D'Aversa, Eugenin, Lopez, & Berman,
2012). The ideal therapy would address the physical limitations associated with SCI,
along with promoting regeneration that is similar in architecture to the original tissue.
The Neuron-vascular Link
During embryonic development, the nervous system and the vascular plexus
share a very close association. The formation of the nervous system undergoes many
stages of remodeling before reaching maturity, as is the case with the vasculature. Both
systems experience a rapid formation, followed by a phase of reshaping and pruning to
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achieve the proper distribution (Arese, Serini, & Bussolino, 2011). As the CNS is
developing, the absence of vascular precursor cells makes the infiltration of blood
vessels a critical process for continued development and cell survival. Crosstalk
between the nervous and vascular systems is a process that helps to establish the
intricate association of the two systems throughout life (Bautch & James, 2009).
Previous studies have shown that cells purified from the bone marrow have the
ability to differentiate into neurons in the human brain (Mezey et al., 2003). It has been
also shown that neural stem cells can be made to produce various blood cell types
when implanted into the hematopoietic system (Bjornson, Rietze, Reynolds, Magli, &
Vescovi, 1999). This illustrates that the neurovascular relationship is very closely
associated, to the point that cells from one system can substitute for cells of the other.
Along with these observations, it is also known that both neurons and blood
vessels share many of the same molecular cues during development. For instance
Semaphorins, once thought to be involved only with axon guidance, have been shown
to play a role in the developing vascular system as well. Proteins that are crucial in
synaptic function have been found to be expressed by ECs as well. The expression of
neurexin and neuroligins in endothelial and smooth muscle show the close relationship
between the two systems (Arese et al., 2011). This interdependence of neuronal and
vascular systems illustrates the possible importance of promoting re-vascualrization
after SCI. If done correctly, promoting angiogenesis into an area of damaged spinal
cord may facilitate the infiltration and establishment of new axonal connections.
Creating a bridge
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There are many physical obstacles which must be overcome in order to
effectively repair a SCI. With contusional SCI, cell death via liquefactive necrosis along
with the formation of the gliotic scar, result in a fluid filled cyst. This cyst creates a
physical gap which regenerating axons and vessels cannot traverse. In order to
overcome this obstacle these physical barriers must be addressed. One approach is to
utilize a structure which contributes to axonal regeneration as well as angiogenesis.
Many approaches have been explored by other research groups to bridge this gap
using various types of scaffolds and bridging materials.
There has been some success in promoting cellular growth into a graft (Cholas et
al., 2012), (Bunge, 2008), but very few have successfully coaxed axons from one side
of the gap to the other. Even more importantly, there seems to be an axon centric view
of regeneration with these models, with little if any thought given to the establishment of
a vascular supply. In order for a bridging strategy to be fruitful, the bridge has to have
several characteristics: the bridge must be biocompatible, elicit little if any immune
response, direct the growth of axons, and activate an angiogenic response. The bridge
must have a solid 3D structure, but be permeable enough for cellular infiltration. The
method used in our lab, air gap electrospinning, is a method which can fulfill all of these
criteria. Illustrated in Figure 1.5, the spinning apparatus allows us to create a 3D
structure with high tensile strength and porosity. This technique allows the grouping 8090 million longitudinally aligned fibers in a 1mm diameter implant. The material used to
spin the fibers is known as Polydioxanone Suture (PDS), which is an FDA approved
absorbable suture. It is biocompatible compound that can persist in vivo for up to six
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months. The fibers created using this process have shown the ability to not only direct
axon growth, but elicit an angiogenic response as well (Chow et. al, 2009; Lin, 2010).
In this particular study, we will be focused on the potential of the implant to evoke
an angiogenic response. It has been shown in previous studies in our lab that
endothelial cells tend to associate with monofilaments (Lin, 2010). By controlling the
concentration of PDS used in the electrospinning process, we can effectively control the
overall size of the fibers present within the implant. Lower concentrations produce a
predominance of smaller diameter fibers, and higher concentrations produce fiber with
larger overall diameters. We hypothesize that ECs will infiltrate scaffolds with smaller
diameter fibers to a greater degree than scaffolds with larger diameter fibers. Scaffolds
with smaller fibers produce greater overall surface area for EC’s, as well as other
essential cell types, to use for migration into the lesion area. This will lead to a greater
angiogenic response than scaffolds containing larger fibers.
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Figure 1.1 Fluid Filled Cyst. An illustration representing the fluid filled cavity and the
surrounding glial scar which forms following SCI. This image was altered from
McDonald et al. (1999).

.
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Figure 1.2 Spinal Cord Blood Supply. This is an illustration showing the arterial blood
supply to the spinal cord. This image was borrowed from Martirosyan et al (2011).
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Figure 1.3 The Neurovascular Unit. This is an illustration showing the cells which
compose the neurovascular unit. This unit is what creates the Blood Brain/Spinal Cord
Barrier. This image was borrowed from Chen and Liu (2012).
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Figure 1.4 Spinal Cord Injury Pathology. (A) Cross section of a normal human spinal
cord at the cervical level. (B) Solid cord injury with related loss of cellular architecture.
(C) Contusion/cavitation injury with associated fluid filled cyst. (D) Laceration injury with
pial disruption. (E) Massive compression injury showing tissue loss and hemmoraging.
Scale bar for images A-E represent 2mm. (Norenberg et al., 2004)
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Figure 1.5 The Air-Gap Electrospinning Setup. This illustration shows the setup for
Air-Gap Electrospinning. This system requires a high voltage DC power supply which
connects to both the needle tip (18-guage, blunt end) and the two grounded poles
between which the 3D scaffold is formed.
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Chapter 2
Methods and Materials

Air Gap Electrospinning:
Polydioxanone Suture, or PDS (monofilament suture, Ethicon) is dissolved in
1,1,1,3,3,3 hexafluoro isopropanol (Sigma Aldrich) at a concentration of 100 mg/ml and
another at 150 mg/ml. This solution is then ready to be electrospun, and is placed within
a 5-ml syringe fitted with an 18-guage blunt end needle. The syringe is then placed into
a syringe pump which allows for the precise control of disbursement of the PDS
solution. The tip of the needle is attached to a high voltage, low amperage DC power
supply (Spellman CZE1000R) by way of an alligator clip, and is charged to 22 kV. Two
grounded horizontal poles separated by a 5-10cm gap composed of a two pole system
which is used to capture the fibers as they are produced (Figure 1.5). This system
results in the production of cylindrical monofilaments ranging in diameter from 1-12 μm.
Theses fibers are collected between the two poles, and are arranged parallel to one
another creating an overall cylindrical structure which becomes the core of the implant
itself. The overall alignment of the monofilaments was determined by analyzing images
taken on a scanning electron microscope (SEM). These photos were examined using
Image J software and conducting a Fast Fourier Transformation, and it was determined
that the monofilaments in both implants were highly aligned (Figure 4.2E).
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Addition of the Outer PGLA capsule:
Upon completion of the core of the matrix via the airgap electrospinning, there is
the addition of a secondary copolymer Polyglycolic-Lactic Acid (PGLA). PGLA consists
of 50% polyglycolic acid and 50% polylactic acid, and is prepared in the same manner
as the PDS mentioned earlier. The application of the PGLA is done by using a grounded
plate in place of the two pole system. The matrix is placed on the grounded plate, and is
moved to the appropriate distance from the charged needle. Upon application of the
voltage, the PGLA copolymer is electrospun toward the grounded plate. The PGLA is
allowed to accumulate onto the PDS matrix, with the fibers arranged perpendicular to
the PDS fibers. The PDS matrix is periodically rotated to ensure it is evenly coated. This
process effectively encapsulates the matrix and effectively holds the PDS
monofilaments together. The capsule also helps to direct the flow of infiltrating cells into
the matrix from either side rather than at any point along its length.
Animal Procurement and Treatment:
All animal work in this study was done following the VCU IACUC approved
protocol. Animals were obtained from Harlan Inc. The rats used in this study were 100
day +/- 10 day old female Long Evans Hooded rats.
Animal groups
Six separate groups were used in this study to observe the progression of
angiogenesis over time. An n-number of 3 was used in each group for a total of 18 rats.
The groups that were examined received electrospun PDS scaffolds of 100mg/mL or
150 mg/mL at 1 week, 1 month, and 2 months.
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Surgical Procedure:
The rats were anesthetized with 5% Isofluorane (AERANE) in a gas chamber
initially, and then transferred to the surgical table and placed into a nose cone which
delivered 3% Isofluorane throughout the duration of the surgery. The animal was placed
onto a warming blanket and a rectal temperature probe was inserted to monitor the
animal’s core temperature. The back of the animal was then shaved and the skin
treated with Betadine to ensure an aseptic surgical site. A dorsal midline incision was
made using a #10 blade scalpel to expose the muscles of the back. Two additional
incisions were made along either side of the spinous processes, and tissue spreaders
were inserted underneath incised muscle. The tissue spreaders were then opened in
order to expose and allow access to the vertebrae. The location of the T9 vertebrae was
identified via palpation of the back. The spinous process was then removed using a pair
of Rongeur’s, allowing access to the space between T9 and T10. Rostral portions of the
T10 lamina were removed in order to create a wider space between the vertebrae, and
the spinal cord was then transected using a pair of micro scissors. A 1mm section of the
electrospun matrix (either 100 mg/ml or 150mg/ml depending on group) was then
inserted into the lesion site. Upon completion of matrix insertion, the tissue spreaders
were then removed and the muscular incisions were close using silk suture (Ethicon).
The skin was then stapled closed using Mitchell staples (FST). An antibacterial
ointment (Bacitril) was applied to the incision site to prevent infection.
Post Operative Care:
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Upon completion of surgery, rats were placed onto a heating pad and monitored
until restoration of consciousness. Rats were then given IP injections of Gentamicin
(10mg/kg) and Buprenorphine (0.5 mg/kg). Buprenorphine was administered in 12 hour
intervals for the first 48 hours post operation. Rats were also given injections of
Gentimycin for 7 days post operation to prevent bacterial infection. Acetaminophen
(150 mg/kg) was administered via addition to drinking water for 3 days post operation.
Bladders were voided of urine manually every 8 hours until the rats regained bladder
function. Upon diagnosis of bladder infection, rats were treated with 5 day cycles of
Gentimycin.

Assessing Functional Recovery: Basso-Beattie-Breshnahan Locomotor Rating Scale:
The BBB locomotor rating scale is a well known and widely used behavioral test
to quantify animal behavior and functional recovery. The rats are scored on a 21 point
scale according to the amount of hind limb motion observed. The scale ranges from a 021; 0 being complete hind limb paralysis, and 21 being fully functional hind limb mobility.
The test assigns points in relation to number of joints involved, coordinated movement
of limbs, weight bearing ability, and gait stability. The rats were first evaluated preoperatively for 4 minutes in an open field to ensure all animals began at a score of 21,
indicating no pre-existing motor deficiencies. To assess the functional recovery post
operatively, the animals were placed into an open field (a large round top table with a
clear plexiglass wall enclosing the animal) and allowed to move freely about the space
for a 4 minute period. Animals were monitored by two separate viewers, and a score
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was assigned based on the observed movement in relation to the scale. The animals
were evaluated on a weekly basis for the duration of the experiment (1- 8 weeks).
Tissue Collection:
All rats were euthanized using a pentobarbitol agent Euthasol (150 mg/kg)
injected intraperitoneally to induce anesthesia and were transcardially perfused with 0.1
M phosphate-buffered saline (PBS). Animals were then fixed using 4%
paraformaldehyde for immunohistochemistry, or a 4% paraformaldehyde and 1%
glutaraldehyde mixture if the tissue was to be processed for electron microscopy (EM).
The spinal cords were then dissected out of the spinal columns and place into conical
flasks containing paraformaldehyde or paraformaldehyde/glutaraldehyde mixtures for 48
hours at 4 degrees Celsius. Spinal cords which to be sectioned for
immunohistochemistry were then transferred to a 30% sucrose solution for 24 hours at
4 degrees Celsius. 40μm thick longitudinal and coronal sections of the implant site and
bordering spinal tissue were cut using a cryostat.
Immunohistochemistry:
The antibody Rat Endothelial Cell Antigen-1(RECA-1) was used to identify newly
formed vasculature within the injury site. RECA-1 labels endothelial cells which allows
for the visualization of the vasculature when combined with a fluorescent-conjugated
secondary antibody. All sections were blocked with 10% normal goat serum (NGS) in
0.1M PBS. Sections were then washed in PBS and incubated with primary antibody
(RECA-1) (1:100) in 1.5% NGS in PBS overnight at 4 degrees Celsius. Sections were
then washed again in PBS and then incubated with Alexa Fluor 598 (1:400) fluorescent
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conjugated secondary antibodies (Invitrogen). Sections were then stained using
Bisbenzimide (1:1000), an intercalating agent which labels cell nuclei by inserting itself
in between Adenine-Thymine base pairs. Slides were then washed 3 times in PBS.
Sections were then immersed in mounting media (Vectashield) and coverslipped. The
presence of RECA-1 positive vessels was determined using a Leica confocal
moicroscope. The number of vessels present per section was determined using IP Lab
software. Confocal images of coronal sections were opened in IP lab, and vessels were
counted by outlining each RECA-1 positive vessel resulting in an overall vessel count
per section.
Transmission Electron microscopy:
Processing for EM began with implantation site being post-fixed in buffer
gluaraldehyde and then in 1% OsO4 for 1 hour. The section was then dehydrated
through an ethanol series and then infiltrated overnight in epon/araldite. Semi-thin
(1μm) coronal sections were obtained and stained with toluidine blue. These sections
were used to affirm that the correct portion of the lesion area was exposed and ready to
be cut into thin sections (500 nm) for EM. Monofillament diameters were measured by
taking representative grids though the middle of the lesion/implant site using a Joel
JEM-1230 transmission electron microscope.
Scanning Electron Microscopy
Imaging of 100mg/mL and 150mg/mL implants was done using a Zeiss EVO 50 XVP
scanning electron microscope. Samples of matrix were sputter coated with gold and
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inserted into the microscope for visualization. Monofilament diameters were measured
using SmartSEM visualization software.
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Chapter 3
Histological Study of the Vascular Supply in the Rat Spinal Cord
Introduction:
Following a spinal cord injury, there is a disruption to the normal vascular
architecture. The vascular supply is fundamental to the growth, function and survival of
all of the cells within the spinal cord as well as the rest of the body. Vessels infiltrating
the tissue are responsible for providing oxygen and other trophic factors as well as
removing cellular waste products. Inflammation and other secondary mechanisms,
including gliotic scar formation, and the loss of vascular function will prevent the
regeneration of tissue in the damaged areas. Following SCI, it is imperative to reestablish a vascular network in order to provide an environment conducive to
regeneration. In this chapter we will examine the distribution of vessels within normal
spinal cord tissue. We will also explore our novel method for inducing an angiogenic
response by utilizing an electrospun matrix.
Vessel Distribution in the Spinal Cord
The vascular supply in the spinal cord has a very distinct pattern that is apparent
when examined through histological means. As we look at a coronal section of the
normal rat thoracic spinal cord (Figure 3.1A), we can see clear delineation of the white
and gray matter. The characteristic butterfly pattern in the center of the section marks
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the gray matter; an area composed of neuronal cell bodies and other associated
support cells. The area surrounding the gray matter is the white matter where the
various axonal tracts are located.
Utilizing an antibody known as Rat Endothelial Cell Antigen-1 (RECA-1), it is
possible to visualize the vascular network and the relative distribution of blood vessels.
The majority of the vessels within the cord are located within the gray matter. This
dense network of vessels is needed to support the high metabolic demand of the
neuronal cell bodies which occupy this area. The vascular supply found within the white
matter, the axonal bearing area of the spinal cord, is much less dense and is distributed
over a wider area. The vessels radiate inward from the surrounding pial arterial plexus
toward the core, and are distributed in a radial fashion (Figure 3.2A). A closer
comparison of the white and gray matter shows a clear difference in blood vessel
distribution (Figure 3.2B).
Angiogenesis and the Scaffold
One of the major hurdles to overcoming SCI and promoting functional recovery is
the reestablishment of the vascular supply. In order to recreate an environment similar
to the normal tissue, it is imperative to induce angiogenesis in a way that mimics the
original vascular architecture. In this study we wanted to further explore the ability of the
scaffold to induce an angiogenic response, and to compare vessel density and
distribution within the matrix to that of normal tissue.
As the electrospinning process in our lab has evolved, it has been demonstrated
that scaffolds with monofilaments that are highly aligned allow for greater cellular
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infiltration into the graft, as opposed to matricies with randomly oriented fibers (Figure
3.3). Other studies utilizing the aligned matrix have shown that in some instances
infiltrating ECs were interacting with the monofilaments as they entered the scaffold
(Figure 3.4A). It was hypothesized that the ECs were using monofilaments as a
template for growth and infiltration. The vessels began to grow and increase their
luminal size, and began to disassociate from the monofilaments (Figure 3.4B, C).
Ultimately these newly formed vessels began functioning, confirmed by the presence of
circulating red blood cells (Figure 3.4D, E).
The use of the aligned scaffold in this study was preferred due to the ease of
cellular infiltration, as well as the ability of monofilaments to interact with incoming
endothelial cells as described. It was also thought that due to the highly aligned nature
of the fibers in the scaffold, the in growth of blood vessels from the rostral and caudal
ends of the lesion could achieve a more direct path through the scaffold. By virtue of
this spatial arrangement, this directed growth may allow tissue to maintain the same
plane as is seen in the normal spinal cord. For instance, blood vessels in the dorsal
columns rostral to the lesion would be connected by monofilaments to vessels on the
caudal side. By maintaining this spatial relationship, it may be possible to facilitate faster
regeneration and anastamosis of vessels on both sides of the lesion.

38

39

Figure 3.1 Normal Rat Spinal Cord. A cross section of a normal rat spinal cord at the
thoracic level showing the delineation of white matter versus gray matter. The section is
oriented with the dorsal end at the top of the image.
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Figure 3.2 Vasculature in the Normal Thoracic Spinal Cord. (A) Cross section of a
normal rat spinal cord stained with RECA-1showing blood vessel distribution in white vs.
gray matter. (B) Close up of blood vessels in white versus gray matter showing greater
overall density in the gray matter.
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Figure 3.3 Cellular Infiltration. DIC images of aligned versus unaligned fibers.
Corresponding cellular infiltration is shown through DAPI staining of cell nuclei. The
cells in the implant with aligned fibers are greater in number and more evenly distributed
than those in the unaligned implant.
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Figure 3.4 Monofilament-Endothelial cell Interaction. (A) LM photograph of
endothelial cell tightly associated with a monofilament. (B, C) LM photograph showing
ECs beginning to dissociate from the monofilaments. (D, E) LM photograph showing
vessel lumens containing monofilaments and circulating red blood cells.
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Chapter 4
Generation and Testing of Bridges with Varying Monofilament Diameters
Introduction:
Spinal cord injuries present many obstacles that must be overcome in order to
facilitate functional recovery. Most often the axons which carry sensory and motor
information to and from the brain are damaged or severed, leaving an individual with
varying losses of function. The secondary injuries to the damaged areas, which include
the formation of a fluid filled cyst and the creation of the gliotic scar, inhibit axonal
regeneration and revascularization. A novel therapeutic strategy is required to
overcome these physical limitations and create an environment in which cells can
survive. Our aim is to address these problems by using a biologically compatible
structure on which regenerating axons and infiltrating endothelial cells can grow. To do
this we utilized air-gap electrospinning in combination with a biocompatible material;
PDS, an type of suture that breaks down naturally in the body over a certain course of
time.
We have shown in previous experiments that our electrospun scaffolds serve
exactly this function. One experiment shows that the highly aligned fibers in the
scaffolds direct the outgrowth of nurites in the same direction and orientation of the
monofilaments (Figure 4.1). Another experiment conducted in our lab demonstrated the
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monofilaments interacting directly with infiltrating blood vessels. The Endothelial cells
which compose these vessels are seen wrapping monofilaments, and over the course
of time the filament breaks down resulting in a lumen. In some instances vessel lumens
can be observed containing deteriorating monofilaments accompanied by red blood
cells, indicating the creation of a functioning blood vessel. Motivated by these
observations, it is our hypothesis that endothelial cells may be attracted or influenced by
monofilaments of a certain size. To test this hypothesis we created two separate
implants, each implant having fibers within a specific range of diameters. One of the
implants contains smaller diameter fibers, and the other containing fibers with larger
diameters overall.
Creating the Bridges
Two separate concentrations, 100 mg/mL and 150 mg/mL, of PDS were used to
create scaffolds with different fiber diameters. The 100mg/ml concentration created a
scaffold with fibers that were between 1- 1.8 micrometers in size, respectively.
Concentrations of PDS at 150mg/mL yielded a scaffold with larger monofilaments in the
2- 2.8 micrometer range (Figure 4.2D). Images of the 100mg/mL and the 150mg/mL
implants were taken at the same magnification, and the fiber diameter measurements
were made using Zeiss SmartSEM software. The difference in the fiber size can be
seen readily when comparing SEM photos of fibers electrospun at different
concentrations (Figure 4.2 A, B, C). Monofilaments within the scaffolds need to be
highly aligned in order to give the straightest possible route for incoming cells into the
lesion area. Using ImageJ software, a calculation known as a Fast Fouier Transfom
(FFT) was performed to determine the overall alignment of the monofilaments. The FFT
48

confirmed that our scaffolds have significant alignment in the desired direction as
indicated by the graph (Figure 4.2 E).
Results:
For this experiment, a full transection was performed at thoracic level 9. Using
this particular type of injury allows for easy insertion of the electrospun scaffolds. The
two implant types were inserted into animals, and animals were allowed to survive for
three separate time periods; 1 week, 1 month, or 2 months. These time points
correspond to two of the various phases of recovery following spinal cord injury. The
first phase is referred to as acute, and takes place seconds to minutes after the initial
insult. The next phase is referred to as secondary, and takes place minutes to weeks
after an injury. The final phase is known as chronic, and can take place over the course
of months to years after injury. These three separate time points allow us to analyze
how vascularization is influenced by the two separate scaffolds during the secondary
and chronic phases, and how this may aid in mitigating secondary injury progression
and promoting regeneration.
Histology
The analysis of the vessel distribution was examined by removing the spinal
cord, and then sectioning the implanted site coronally. 40um thick sections from the
center of the site were then stained with RECA-1 to label the vasculature. The RECA-1
positive vessels in each section were counted using IP lab software. The overall vessel
numbers in the 100 vs.150mg/mL groups for each time point were compared to the
number of vessels in a normal thoracic spinal cord section. The total number of vessels
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counted in each experimental animal was normalized to the number of vessels found at
a comparable spinal cord level in an uninjured control animal (Figure 4.3).
A large degree of variance was observed over each time point between each
experimental group when normalized to an uninjured control animal, but the 100 groups
consistently had a greater number of vessels than the 150 groups. This suggests that
the scaffolds containing smaller diameter fibers induce a greater angiogenic response
than scaffolds containing larger diameter fibers.
An interesting progression of angiogenesis can be seen when sections of the two
scaffold types are compared. In the one week groups, both the 100 (Figure 4.5 A,B) and
150mg/mL (Figure 4.5 C,D) implants showed the presence of infiltrating blood vessels.
When the vessels were counted, the 100mg/mL implant contained 242 individual
vessels as oppsed to the 150mg/mL which contained 148.
The 1 month groups showed a further increase in blood vessel formation. The
100mg/mL group contained a significantly larger number of vessels (690), as opposed
to the 150 mg/mL group (422). The vessels in the 100 group were smaller in diameter
and more tightly packed together (Figure 4.6 B), while the 150 group showed vessels
with larger diameters that were spaced farther apart (Figure 4.6D). The tissue in the100
group was also observed to have better overall continuity than the 150 (Figure 4.6A).
The absence of vessels and tissue in the center of the in the 150mg/mL implant area
suggests the beginning of cystic cavity formation (Figure 4.6C).
When examining the 100 versus the 150mg/mL sections in the two month group,
we see that the 100 group produces better results than the 150. The number of vessels
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in both of the 2 month groups decreased from the levels found in the 1 month groups;
the section from the100 group contained 410 vessels, whereas the section from the150
group contained 264. The 100mg/mL section shows vessels that are evenly distributed,
as well as having similar diameters (Figure 4.7 B). Vessels in the 150 group vary widely
in size and distribution, and very little tissue is left intact (Figure 4.7 D). Both the 100
and 150 groups show the development of cystic cavities (Figure 4.7 A,C), but the
difference in cavity size and tissue sparing is quite dramatic. The 100mg/mL section
shows the development of a cystic cavity, but the 150mg/mL section has developed a
cavity which occupies nearly the entire section.
One problem that required some further attention was the presence of holes or
cavities within the individual sections. While the normalized vessel counts (Figure 4.3)
compared the total number of vessels in each group to that of the control animal, in
order to determine the vessel density, or vessels per unit area, the holes in the tissue
had to be accounted for. Once the actual tissue area was determined by subtracting out
the empty spaces, the percent of tissue occupied by vessels was able to be determined.
The percent of tissue occupied by vessels at each time point within each group
was examined (Figure 4.4), and again we see that the 100 mg/mL group had a higher
percentage of vessels occupying the tissue than the 150 mg/mL group. However, at the
2 month time point, the two groups have very similar percentages, with the 100 mg/mL
group being only slightly higher than the 150 mg/mL group, but the amount of tissue
remaining in the 150 mg/mL group is two thirds that of the 100 mg/ml group.
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The differences in the number and distribution of blood vessels in the 100 vs. the
150mg/mL groups are quite remarkable. Not only does the 100 group stimulate the
production of more vessels than the 150, but the development of the cystic cavity
appears to be greatly reduced in the 100 group as well. These observations suggest
that scaffolds electrospun at 100mg/ml of PDS are superior in terms of decreasing
secondary injury progression as well as promoting a greater angiogenic response.
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Figure 4.1 Neurite Growth. (A) Neurite outgrowth from a DRG on an unaligned
electrospun matrix radiates outward in a randomized fashion. (B) Neurite outgrowth
from a DRG on an aligned matrix is oriented in the direction of the fiber alignment,
illustrating the aligned fibers ability to direct cellular growth. The neurites were stained
using Tuj1. The scale bar represents 200um. This image was borrowed from Chow et al
(2009).
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Figure 4.2 Fiber Size and Orientation. (A,B,C) SEM images showing an increase in
fiber diameters as the concentration of PDS is increased. (D) Graph comparing the
range of fiber diameters in 100mg/mL versus 150mg/mL electrospun scaffolds. (E) An
FFT confirming the majority of the fibers at varying concentrations are highly aligned.
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Figure 4.3 Scaffold Vascularization Percentages. Bar graph showing normalized
vessel counts at the three separate time periods. The 100mg/ml implants show greater
vascularization than the 150 mg/mL implants over all three experimental time points.
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Figure 4.4 Vessels Per Unit Area. Bar graphs showing normalized vessel counts per
unit area. This graph has been adjusted to take into account the empty space that is
found in the implant area.
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Figure 4.5 One Week Scaffolds. (A) Confocal image of a 100mg/mL implant from a
one week animal. The fibers are smaller and pack tightly together, leaving few gaps in
the implant. (B) A close up view of vessels outlined in panel A. (C) Confocal image of a
150mg/mL implant form a one week animal. The fibers have a larger diameter and may
contribute to the layering effect creating more gaps. (D) A close up of the vessels
outlined in panel C.
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Figure 4.6 One Month Scaffolds.(A) Confocal image of a 100mg/mL implant from a
one month animal. The tissue remains relatively intact. (B) A close up view of vessels
outlined in panel A. (C) Confocal image of a 150mg/mL implant form a one month
animal. The beginning of a cystic cavity can be seen in the center of the section. (D) A
close up of the vessels outlined in panel C.
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Figure 4.7 Two Month Scaffolds.(A) Confocal image of a 100mg/mL implant from a
two month animal. A cystic cavity can be seen at the center of the tissue. (B) A close up
view of vessels outlined in panel A. (C) Confocal image of a 150mg/mL implant from a
two month animal. A very large cystic cavity has formed, leaving very little intact tissue.
(D) Close up of the vessels outlined in panel C.
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Discussion
The Angiogenic Response
Having a functioning blood supply is essential to the survival of an organism. It
provides the essential nutrients needed to keep the cells of the body healthy and
functioning. The ability of blood vessels to infiltrate damaged tissue is essential in
creating and maintaining new tissue. In the case of spinal cord injury, harnessing the
power of the angiogenic response may be the key to promoting regeneration and
ultimately meaningful recovery.
Some experiments have shown the ability to stimulate angiogenesis using
implants along with other factors included. One study showed that a bridge composed
of micoporous hydrogel along with a neural progenitor/ endothelial cell culture could
stimulate an angiogenic response (Rauch, M.F., 2009). Other approaches include
collagen linked scaffolds with various cell types placed inside to stimulate a reparative
response (Ramatullah,H.C., 2011). However, most bridging studies do not focus
primarily on the angiogenic response, and if they do, there are often many variables
which may be influencing this response. Our study focuses on one bridge with no other
factors involved, to find out if altering the physical properties of the scaffold alters the
angiogenic response.
We have seen that our electrospun scaffolds have the ability to induce an
angiogenic response in the injured spinal cord. It has also been shown that by
manipulating the fiber diameters in our scaffolds by altering the concentration, we can
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manipulate the number of newly forming blood vessels. The ability of the scaffold to
elicit and angiogenic response is a fascinating feature of our experimental model. The
infiltrating blood vessels create an environment that is more suitable for regeneration to
occur, but how is this process taking place? One theory is that as the scaffold is placed
into the transected spinal cord, the severed vessels begin to infiltrate in a pattern that
mirrors the original vascular architecture. The tightly grouped capillaries of the gray
matter would be reflected within the scaffold. We would expect to see more vessels in
the center of the scaffold than in the peripheral areas. We would also expect there to be
larger caliber vessels seen in the outer areas, which would reflect the reestablishment
of the arterial blood supply.
From a biological standpoint, the reason angiogenesis occurs is to fulfill the basic
needs of the cellular environment. This includes supplying oxygen and carrying away
carbon dioxide and other metabolic wastes from tissue, as well as supplying other
essential nutrients. During the healing process, one of the first cellular responses is the
establishment of new blood supply. This same reparative response is taking place at the
site of injury in our animal model, and we believe that the scaffolds are providing a
guide for regenerating blood vessels. One of the driving forces of the angiogenic
response is lack of oxygen. In a hypoxic environment, cells begin to release VEGF
which induces existing vessels to sprout and extend toward the area that requires
oxygen. The scaffold is an area that is devoid of any blood supply initially, so we believe
that any cells which migrate into the scaffold would begin to release VEGF in an attempt
to recruit the necessary blood supply.
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One possible explanation for the larger number of vessels in the 100mg/mL vs
the 150mg/mL groups is a matter of space. The 100mg/mL scaffold has a tighter
grouping of monofilaments than the 150mg/mL scaffold, along with fewer cavities. This
provides a greater surface area for cellular infiltration in the 100mg/mL scaffold. Due to
the greater number of cells entering the 100mg/mL scaffold, there would be a larger
volume of VEGF being released which would stimulate a more robust angiogenic
response. In the 150mg/mL scaffold, no cellular infiltration or blood vessel growth can
take place in areas that have no monofilaments, making the number of cells entering
the 150mg/mL scaffold fewer than the 100mg/mL scaffold. This would result in less
VEGF being released from infiltrating cells, and therefore less angiogenesis would
occur.
Histology
As we examine the histology, it appears that animals receiving the 100mg/mL
implants show a greater angiogenic response than those that received the 150mg/mL
implant. In both cases the number of vessels found in the center of the graft area began
to increase over time, peak and then decrease at the latest time point. One explanation
for this is the fact that at 1 week, cells have just begun to make their way into the
scaffold, and the amount of VEGF being released is not as high as at the later time
points. At one month the scaffolds are filled with cells, all releasing VEGF and in turn
calling for a larger amount of vessels to meet their demands. At 2 months we see a
decrease in the number of vessels. This may have to do with the natural pruning
process that occurs after the initial angiogenic response; the vessels that are redundant
or not required are removed. Another reason for the deceased number at 2 months is
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the development of the cavities at the center of the lesion area, and there is simply less
area for vessels to occupy.
At all three time points, the 100 groups displayed a greater number of vessels
than the 150 groups overall. It was also observed that the increased vascularity
produced by the 100mg/mL implants facilitated tissue sparing to a greater degree than
the 150. Both animals in the 2 month groups developed cystic cavities, but the cavity
formed in the 100 animal was significantly smaller in size. The cavity formed in the 2
month 150 animal was very large, leaving very little intact tissue. These initial findings
suggest that our hypothesis regarding fiber diameter is correct. Smaller diameter fibers
appear to increase angiogenesis, and that increased vascularity promotes greater
tissue regeneration.
Methodology
Having compared the differences in histological outcomes using the two separate
scaffolds at three distinct time points, we can see that there is a difference in angiogenic
response produced by the two separate concentrations. There are some factors
involved with the method of implantation that could be improved. The implantation
surgery consisted of a thoracic laminectomy, followed by a complete spinal cord
transection with a pair of microscissors. The implants were then inserted into the lesion
area, and the surgical site was then closed. In the future, it may be beneficial to ensure
the implant is secure in the lesion site and cannot be displaced when the animal moves
about. This may help to increase the regenerative process by keeping the implant in the
same orientation throughout the healing process, preventing possible damage to the
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newly formed vasculature. While technically challenging, one approach to solving this
problem would be to surgically deflect the dura before making the transection, and then
sealing the dura after the implant is inserted. This could be done with suture or some
type of surgical glue.
Limitations
There are many limitations associated with a study of this kind. The injury itself is
quite traumatic, and the recovery of the animals post surgery can be difficult. The
morbidity rate in this type of study is high, and losing animals due to complications limits
the scope of the study. It is also difficult to ensure each animal has experienced the
same amount of trauma; in some animals there is a full transection, while other animals
appear to have a small amount of undamaged tissue at the ventral aspect of the cord.
This inconsistency could produce varying degrees of difference in the final histological
outcome.
Another factor that limited this particular study was the surgeons performing the
surgeries. Two separate surgeons performed the surgeries in this study. Both had to be
trained in the surgical technique, and the initial surgeries were of lesser quality than
those performed later in the study. It is essential that in the future, the surgeon should
be well trained in the proper surgical technique and its associated complications.
Limitations associated with the electrospinning process and the consistency of
implant production need to be addressed as well. In some cases, the ability to
electrospin effectively can be affected by factors such as the temperature or humidity in
the spinning area. The overall diameter of the implant was also inconsistent in this
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study; in some cases the implant itself was smaller than the diameter of the spinal cord.
This limits the regenerative potential by not providing the proper structural support and
guidance offered by the scaffold to the entire affected area.
Finally, the number of animals used in this particular study was low. Initial
observations suggest that the 100mg/mL implant induces greater angiogenesis than the
150mg/ml implant. In order confirm that this is consistently the case, more animals need
to be studied. This would include using the highest quality bridges, along with proper
and consistent surgical technique.
Future Experiments
Directions for the future of the electrospun scaffolds will incorporate other factors
within the implant itself to further aid in tissue sparing, regeneration, and functional
recovery. It is thought that by employing a combinatorial strategy, we can increase the
overall recovery of the animals. Factors that would be added to increase the overall
effectiveness of the implant include both chemical and cellular cellular elements.
It has been shown in a previous study in our lab that the molecular fusogen,
Polyethylene Glycol (PEG), increases the functional recovery of animals when used in
conjunction with the implants (Dalton, 2011). It is believed that the use of PEG seals
damaged axonal membranes, preventing neuronal cell death and promoting the
sprouting of new axons. Another study conducted in our lab has shown that the
incorporation of Schwann cells into the scaffold also increases functional recovery
(Kanaan, 2012). It is thought that the Schwann cells are providing the necessary
myelination of newly formed axons, allowing for proper signal transduction.
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Future studies to promote regeneration following SCI will incorporate many
factors. Using the proper fiber diameter to induce the greatest angiogenic response,
coupled with the PEG and cell seeding could prove to be a very effective treatment
strategy. This type of implant, coupled with proper and consistent surgical technique,
has the potential to produce outstanding regenerative results and meaningful functional
recovery. Using these types of strategies in the future has the potential to offer hope to
the millions of people suffering from spinal cord injury.
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